Japan vs Slovenia: Number of isolates tested for ceftriaxone
Japan
134
in 2020
Slovenia
168
in 2020
Japan rank
22nd
Slovenia rank
19th
Number of isolates tested for ceftriaxone over time
- Japan
- Slovenia
How they compare
Slovenia currently reports 168 against 134 in Japan, a difference of 34.
That makes Slovenia's figure about 1.3 times Japan's.
The two have swapped places 1 time across 10 shared years of data; in 2009 it was Japan ahead.
Japan ranks 22nd and Slovenia ranks 19th of 52 countries.
Across the 3 decades both report, Japan averaged higher in 2 and Slovenia in 1.
Head to head by decade
| Decade | Japan | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 403 | 24 | 379 | Japan |
| 2010s | 425.12 | 83.75 | 341.38 | Japan |
| 2020s | 134 | 168 | 34 | Slovenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of isolates tested for ceftriaxone, Japan or Slovenia?
- Slovenia, at 168 against 134 in Japan as of 2020.
- What is the difference in number of isolates tested for ceftriaxone between Japan and Slovenia?
- 34, with Slovenia ahead.
- How many years of comparable data are there for Japan and Slovenia?
- 10 years are reported by both, from 2009 to 2020.
- How do Japan and Slovenia rank globally for number of isolates tested for ceftriaxone?
- Japan ranks 22nd and Slovenia ranks 19th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of isolates tested for ceftriaxone. Statizoid refreshes it automatically from the source and publishes the full history for both places.